Eli Lilly's Heart Drug Lepodisiran Cuts Lipoprotein Lp(a) for Year in Study - Bloomberg
- Eli Lilly's Heart Drug Lepodisiran Cuts Lipoprotein Lp(a) for Year in Study Bloomberg
- Sustained Reductions in Lp(a) Achieved With Novel siRNA Drug Medscape
- One dose of experimental therapy reduced lipoprotein(a) more than 94% for nearly a year American Heart Association
- New medication given every 1-3 months may slash stubborn high cholesterol American Heart Association
- View Full Coverage on Google News